Centene Corporation (NYSE: CNC) has announced that as of 11:59 p.m. on March 12th, 2021, the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to the Company’s proposed acquisition of Magellan Health Inc. has expired.
As previously announced on January 4, 2021, the transaction will broaden and deepen Centene’s whole health capabilities and establish a leading behavioral health platform. The combined platform lays the foundation by which the company will continue to invest and innovate for its members, enabling improved health outcomes and faster, diversified growth.
The transaction is expected to close in the second half of 2021 and is subject to receipt of required state regulatory approvals, the approval of the definitive merger agreement by Magellan Health’s stockholders, and other customary closing conditions.
Source: Biospace.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
